Data / Drug companies / Echinocandin Antifungal
Echinocandin Antifungal drugs: 6 drugs from 18 companies in the FDA NDC directory
Echinocandin Antifungal is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 42 products in this class from 18 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on April 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 18Companies
- 42Products
- 6Drugs by generic name
Drugs in the Echinocandin Antifungal class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Caspofungin acetate | 14 | 7 |
| Micafungin | 12 | 6 |
| Micafungin sodium | 9 | 4 |
| Anidulafungin | 3 | 1 |
| Micafungin in sodium chloride | 3 | 1 |
| Rezafungin | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 8, 2020 |
| Sagent Pharmaceuticals | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 15, 2023 |
| Baxter Healthcare Corporation | 3 | injection | New drug applications (NDA) | September 29, 2023 |
| Roerig | 3 | injection, powder, lyophilized, for solution | New drug applications (NDA) | February 20, 2024 |
| Biocon Pharma Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 1, 2025 |
| Fosun Pharma USA Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 2, 2019 |
| Gland Pharma Limited | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 29, 2017 |
| Glenmark Pharmaceuticals Inc., USA | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 30, 2025 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 8, 2025 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 9, 2021 |
| Hisun Pharmaceuticals USA, Inc. | 2 | injection, powder, for solution | Generic drugs (ANDA) | April 1, 2026 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 28, 2022 |
| Merck Sharp & Dohme LLC | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | January 26, 2001 |
| Qilu Pharmaceutical Co., Ltd. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 3, 2025 |
| Sandoz Inc | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 4, 2018 |
| Zydus Lifesciences Limited | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 10, 2023 |
| Zydus Pharmaceuticals USA Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 10, 2023 |
| Melinta Therapeutics, LLC | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | June 9, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 37 | 88.1% |
| Injection | 3 | 7.1% |
| Injection, powder, for solution | 2 | 4.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.